Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rhizoma Atractylodis Macrocephalae is the dried rhizome of Atractylodes macrocephala Koidz., a perennial herb in the family Asteraceae. Known as Bai Zhu (白术) in Chinese medicine, it is a foundational herb used primarily to tonify Spleen Qi and dry Dampness. In Traditional Chinese Medicine (TCM), it is classified as warm and sweet-bitter in nature and enters the spleen and stomach meridians. Its main actions include strengthening the spleen, augmenting Qi (vital energy), drying dampness through diuresis, stopping spontaneous sweating by stabilizing exterior defenses, calming restless fetus due to deficiency syndromes, and preventing miscarriage. It is commonly prescribed for symptoms such as loss of appetite, abdominal bloating or colic, diarrhea or loose stools, fatigue from Spleen Qi deficiency, edema due to fluid retention from poor spleen function, night sweats or spontaneous sweating from Qi deficiency syndromes; also for threatened abortion related to weakness of the middle Jiao (digestive system). Modern research has identified various pharmacologically active compounds within this herb that may contribute to its effects on gastrointestinal health and immune modulation[2][3][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rhizoma atractylodis macrocephalae.